Physicians’ and patients’ perception of biosimilars and factors affecting biosimilar prescribing in selected Asian Countries: a survey study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Physicians’ and patients’ perception of biosimilars and factors affecting biosimilar prescribing in selected Asian Countries: a survey study

Published:2024-09-05 Issue: Volume: Page:
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Thongpooswan Supat¹^ORCID,Das Anupam²^ORCID,Patil Pravin³^ORCID,Latymer Mark⁴,Llamado Lyndon⁵⁶,Wee James⁵⁷

Affiliation:

1. Bumrungrad International Hospital, Bangkok, Thailand

2. KPC, Medical College, West Bengal, India

3. Pune Rheumatology Center, Maharashtra, India

4. Pfizer, Sandwich, UK

5. Pfizer, Makati, Philippines

6. Department of Medicine, University of Santo Tomas, Manila, Philippines

7. Medical Specialist, Medical Center Taguig, Philippines

Funder

Pfizer

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2024.2400523

Reference37 articles.

1. Anti-TNF Agents as Therapeutic Choice in Immune-Mediated Inflammatory Diseases: Focus on Adalimumab

2. Anti-TNF-α Inhibitors: A New Therapeutic Approach for Inflammatory Immune-Mediated Diseases: An Update upon Efficacy and Adverse Events

3. Infliximab in inflammatory bowel disease

4. Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis

5. Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP